Common Stock, Value, Issued in USD of Renalytix plc from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Renalytix plc quarterly Common Stock, Value, Issued history and change rate from Q2 2018 to Q3 2024.
  • Renalytix plc Common Stock, Value, Issued for the quarter ending 30 Sep 2024 was $515K, a 77.6% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Change (%)

Renalytix plc Quarterly Common Stock, Value, Issued (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $515K +$225K +77.6% 30 Sep 2024 10-Q 19 Nov 2024
Q2 2024 $478K +$192K +67.1% 30 Jun 2024 10-Q 19 Nov 2024
Q1 2024 $368K +$82K +28.7% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $305K +$76K +33.2% 31 Dec 2023 10-Q 14 Feb 2024
Q3 2023 $290K +$61K +26.6% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $286K +$58K +25.4% 30 Jun 2023 10-K 30 Sep 2024
Q1 2023 $286K +$66K +30% 31 Mar 2023 6-K 09 Jun 2023
Q4 2022 $229K +$9K +4.09% 31 Dec 2022 6-K 30 Mar 2023
Q3 2022 $229K 30 Sep 2022 6-K 30 Nov 2022
Q2 2022 $228K +$8K +3.64% 30 Jun 2022 10-K 28 Sep 2023
Q1 2022 $220K 31 Mar 2022 6-K 30 Jun 2022
Q4 2021 $220K 31 Dec 2021 6-K/A 29 Apr 2022
Q2 2021 $220K +$41K +22.9% 30 Jun 2021 20-F 31 Oct 2022
Q2 2020 $179K +$17K +10.5% 30 Jun 2020 20-F/A 01 Aug 2022
Q2 2019 $162K +$96K +145% 30 Jun 2019 20-F/A 01 Aug 2022
Q2 2018 $66K 30 Jun 2018 20-F/A 10 Nov 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.